Volume 54, Issue 2, Pages (August 1998)

Slides:



Advertisements
Similar presentations
Kamyar Kalantar-Zadeh  Kidney International 
Advertisements

Acid-base profile in patients on PD
Optimization of pre-ESRD care: The key to improved dialysis outcomes
Steven Fishbane, Jeffrey S. Berns, M.D.  Kidney International 
Volume 65, Issue 6, Pages (June 2004)
Volume 54, Issue 2, Pages (August 1998)
Volume 59, Issue 3, Pages (March 2001)
E. Cavalier, P. Delanaye, A. Carlisi, J. -M. Krzesinski, J. -P
Use of hemodialysis and hemoperfusion in poisoned patients
Anemia management in chronic kidney disease
Acid-base profile in patients on PD
Volume 90, Issue 5, Pages (November 2016)
C-reactive protein and dialysis access
Volume 55, Issue 2, Pages (February 1999)
Volume 56, Issue 3, Pages (September 1999)
C-reactive protein and dialysis access
Box-And-Whisker Plots
Volume 80, Issue 4, Pages (August 2011)
Kamyar Kalantar-Zadeh  Kidney International 
The progression of chronic kidney disease: A 10-year population-based study of the effects of gender and age  B.O. Eriksen, O.C. Ingebretsen  Kidney International 
Volume 63, Issue 4, Pages (April 2003)
Volume 66, Issue 3, Pages (September 2004)
Joseph W. Eschbach, John W. Adamson  Kidney International 
Volume 61, Issue 6, Pages (June 2002)
Renal risk scores: Progress and prospects
D. Coyne  Kidney International  Volume 69, Pages S1-S3 (May 2006)
Volume 76, Issue 3, Pages (August 2009)
Volume 60, Issue 1, Pages (July 2001)
Bradley A. Ford, Daniel W. Coyne, Charles S. Eby, Mitchell G. Scott 
Volume 67, Pages S48-S51 (January 2005)
Blood pressure targets in hemodialysis patients
Volume 61, Issue 6, Pages (June 2002)
Box-And-Whisker Plots
Box-And-Whisker Plots
Locking of tunneled hemodialysis catheters with gentamicin and heparin
Volume 65, Issue 6, Pages (June 2004)
Volume 73, Issue 9, Pages (May 2008)
Recent experience with high-dose intravenous iron administration
Volume 66, Issue 2, Pages (August 2004)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Proteinuria and hypertensive nephrosclerosis in African Americans
Randomized controlled study of biocompatible peritoneal dialysis solutions: Effect on residual renal function  S.L.S. Fan, T. Pile, S. Punzalan, M.J.
Volume 71, Issue 6, Pages (March 2007)
Volume 78, Issue 8, Pages (October 2010)
Volume 76, Issue 8, Pages (October 2009)
Volume 62, Issue 4, Pages (October 2002)
Higher serum C-reactive protein predicts short and long-term outcomes in peritoneal dialysis-associated peritonitis  N.-Y. Zalunardo, C.-L. Rose, I.W.Y.
Nicotinamide suppresses hyperphosphatemia in hemodialysis patients
Volume 64, Issue 1, Pages (July 2003)
Volume 55, Issue 5, Pages (May 1999)
Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients  B. Bammens, P. Evenepoel, H. Keuleers,
Volume 63, Issue 1, Pages (January 2003)
Why measure serum albumin levels?
Kathy E. Sietsema, Antonino Amato, Sharon G. Adler, Eric P. Brass 
Current status of maintenance hemodialysis in Beijing, China
Volume 64, Issue 3, Pages (September 2003)
Volume 63, Issue 2, Pages (February 2003)
Elevated plasma F2-isoprostanes in patients on long-term hemodialysis
Volume 80, Issue 10, Pages (November 2011)
Volume 65, Issue 4, Pages (April 2004)
Volume 60, Issue 6, Pages (December 2001)
Volume 57, Issue 2, Pages (October 2000)
Thresholds of iron markers for iron deficiency erythropoiesis—finding of the Japanese nationwide dialysis registry  Takayuki Hamano, Naohiko Fujii, Terumasa.
Pediatric in-center hemodialysis patients
Predictors of the response to treatment in anemic hemodialysis patients with high serum ferritin and low transferrin saturation  A.K. Singh, D.W. Coyne,
Volume 59, Issue 3, Pages (March 2001)
Optimization of pre-ESRD care: The key to improved dialysis outcomes
Stephen Pastan, J. Michael Soucie, William M. McClellan 
Intra-individual variability in serum hepcidin precludes its use as a marker of iron status in hemodialysis patients  Bradley A. Ford, Charles S. Eby,
Presentation transcript:

Volume 54, Issue 2, Pages 627-636 (August 1998) C-reactive protein as an outcome predictor for maintenance hemodialysis patients  William F. Owen  Kidney International  Volume 54, Issue 2, Pages 627-636 (August 1998) DOI: 10.1046/j.1523-1755.1998.00032.x Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 1 Box and whisker plot showing the distribution of transformed C-reactive protein (CRP) values for 1,054 ESRD patients. The box defines the upper and lower quartiles, and the mean is shown by the cross. The notch indicates the median. Higher values for CRP are arrayed to the right. Kidney International 1998 54, 627-636DOI: (10.1046/j.1523-1755.1998.00032.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 2 Regression of serum albumin concentration (g/dl) on transformed C-reactive protein (r = -0.254; P < 0.001). Kidney International 1998 54, 627-636DOI: (10.1046/j.1523-1755.1998.00032.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 3 Regression of blood hemoglobin concentration (g/dl) on transformed C-reactive protein (CRP) values (r = -0.235 and P < 0.001). Transformed values correspond to real values as follows: 0 = 0; 0.2 = 0.10; 0.4 = 0.45; 0.6 = 1.29; 0.8 = 3.37; 1.0 = 9.00; 1.2 = 26.54. Upper limits of normal for transformed CRP values is <3.37. Kidney International 1998 54, 627-636DOI: (10.1046/j.1523-1755.1998.00032.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 4 Regression of blood hemoglobin concentration (g/dl) on serum albumin concentration (g/dl) (r = 0.326 and P < 0.001). Kidney International 1998 54, 627-636DOI: (10.1046/j.1523-1755.1998.00032.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 5 Regression of total iron binding capacity (TIBC; μg/dl) on transformed ferritin concentration (r = -0.52; P = 0.001). Kidney International 1998 54, 627-636DOI: (10.1046/j.1523-1755.1998.00032.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Kidney International 1998 54, 627-636DOI: (10. 1046/j. 1523-1755. 1998 Kidney International 1998 54, 627-636DOI: (10.1046/j.1523-1755.1998.00032.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Kidney International 1998 54, 627-636DOI: (10. 1046/j. 1523-1755. 1998 Kidney International 1998 54, 627-636DOI: (10.1046/j.1523-1755.1998.00032.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Kidney International 1998 54, 627-636DOI: (10. 1046/j. 1523-1755. 1998 Kidney International 1998 54, 627-636DOI: (10.1046/j.1523-1755.1998.00032.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Kidney International 1998 54, 627-636DOI: (10. 1046/j. 1523-1755. 1998 Kidney International 1998 54, 627-636DOI: (10.1046/j.1523-1755.1998.00032.x) Copyright © 1998 International Society of Nephrology Terms and Conditions